Abdel‐Baset Halim
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Internal Medicine top 5%
Papers in
-
- RNA modifications and cancer 3
- Oncology 6
- Co-authors
- Malak Kotb (4 shared papers)Arthur M. Geller (5 shared papers)Leighton LeGros (3 shared papers)O. El-Ahmady (5 shared papers)Michael A. Gerber (2 shared papers)S. Dash (2 shared papers)Hélène Legros (2 shared papers)Jeanne Mendell (3 shared papers)
- Journals
- Journal of Biological Chemistry (4 papers)Annals of Oncology (2 papers)The International Journal of Biological Markers (2 papers)Biomarkers in Medicine (2 papers)Thrombosis and Haemostasis (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Abdel‐Baset Halim
34 papers receiving 955 citations
Peers
Comparison fields: 5 of 90
- Hepatology 126
- Internal Medicine 55
- Rheumatology 124
- Pharmacology 73
- Oncology 151
Countries citing papers authored by Abdel‐Baset Halim
This map shows the geographic impact of Abdel‐Baset Halim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdel‐Baset Halim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdel‐Baset Halim more than expected).
Fields of papers citing papers by Abdel‐Baset Halim
This network shows the impact of papers produced by Abdel‐Baset Halim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdel‐Baset Halim. The network helps show where Abdel‐Baset Halim may publish in the future.
Co-authors
The 25 scholars most cited alongside Abdel‐Baset Halim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 114 | |
| 2 | 1999 | 86 | |
| 3 | 2001 | 76 | |
| 4 | 2013 | 76 | |
| 5 | 2000 | 72 | |
| 6 | Transfection of HepG2 cells with infectious hepatitis C virus genome. | 1997 | 69 |
| 7 | 2012 | 61 | |
| 8 | 2001 | 48 | |
| 9 | 1999 | 44 | |
| 10 | 2021 | 42 | |
| 11 | 2013 | 40 | |
| 12 | 2014 | 37 | |
| 13 | 2012 | 35 | |
| 14 | 2018 | 24 | |
| 15 | 2001 | 24 | |
| 16 | 2014 | 23 | |
| 17 | 2023 | 22 | |
| 18 | 2004 | 20 | |
| 19 | 2022 | 13 | |
| 20 | The clinical value of CYFRA21-1 in bladder cancer patients: Egyptian experience. | 1999 | 10 |
About Abdel‐Baset Halim
Abdel‐Baset Halim is a scholar working on Molecular Biology, Oncology, Rheumatology, Immunology and Surgery, having authored 35 papers that have together received 1.0k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (4 papers), Folate and B Vitamins Research (4 papers), Biosimilars and Bioanalytical Methods (3 papers), Clinical Laboratory Practices and Quality Control (3 papers), RNA modifications and cancer (3 papers), Hepatitis B Virus Studies (2 papers), Health and Medical Research Impacts (2 papers) and Hepatitis C virus research (2 papers). The work is most often cited by research in Hepatology (126 citations), Internal Medicine (55 citations), Rheumatology (124 citations), Pharmacology (73 citations) and Oncology (151 citations). Abdel‐Baset Halim has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Malak Kotb, Arthur M. Geller, Leighton LeGros, O. El-Ahmady, Michael A. Gerber, S. Dash, Hélène Legros, Jeanne Mendell, Margaret E. Chamberlin and Naoki Hiramatsu. Their work appears in journals such as Journal of Biological Chemistry, Annals of Oncology, The International Journal of Biological Markers, Biomarkers in Medicine and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.